Schedule 13G ownership disclosure

GW PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 36197T103

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
17,107,201
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000858744-15-000021
Form type
SC 13G
Filer
GW PHARMACEUTICALS PLC
CIK
CIK 1351288
Filed
Feb 13, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub